Skip to content
GCC AI Research

Search

Results for "risk prediction"

Machine Learning Risk Intelligence for Green Hydrogen Investment: Insights for Duqm R3 Auction

arXiv ·

This paper introduces an AI-driven decision support system for green hydrogen investment in Oman, specifically for the Duqm R3 auction. The system uses publicly available meteorological data to predict maintenance pressure on hydrogen infrastructure, creating a Maintenance Pressure Index (MPI). This tool supports regulatory oversight and operational decision-making by enabling temporal benchmarking against performance claims.

UAE: This new AI system can predict heart disease risks up to 12 years in advance - Khaleej Times

Khaleej Times ·

Researchers at Khalifa University have developed an AI system capable of predicting cardiovascular disease (CVD) risks up to 12 years in advance. The AI model uses data from the Framingham Heart Study to assess long-term CVD risk factors. It outperforms existing methods in predicting CVD incidence over extended periods. Why it matters: This advancement could significantly improve preventative healthcare strategies in the UAE and globally by enabling earlier interventions for individuals at high risk of heart disease.

KAUST scientists developing models to predict extreme events

KAUST ·

KAUST scientists are developing models to predict extreme weather events like the 2009 Jeddah flood, which caused significant damage. Prof. Ibrahim Hoteit's team is using data from satellites, international sources, and local entities like PME and the Jeddah Municipality to build high-resolution models. The aim is to improve predictions of extreme rain events by one or two days and issue timely warnings. Why it matters: Improving extreme weather prediction is crucial for mitigating the impact of climate change in vulnerable regions like the GCC.

Forecasting hospitalizations with AI

MBZUAI ·

MBZUAI Professor Agathe Guilloux developed the SigLasso model to forecast hospitalizations using real-time data from Google and Météo France during the COVID-19 pandemic. The model integrates mobility data and weather patterns to predict hospitalization rates 10-14 days in advance. SigLasso outperformed industry standards like GRU and Neural CDE in reducing reconstruction error. Why it matters: This research demonstrates the potential of AI to improve healthcare resource allocation and crisis management by accurately predicting patient flow using readily available data.

Analysis of Longitudinal Phenotypes and Disease Trajectories at Population Scale using Deep Learning

MBZUAI ·

Søren Brunak presented deep learning approaches for analyzing disease trajectories using data from 7-10 million patients in Denmark and the USA. The models predict future outcomes like mortality and specific diagnoses, such as pancreatic cancer, using 15-40 years of patient data. Disease trajectories and explainable AI can generate hypotheses for molecular-level investigations into causal aspects of disease progression. Why it matters: This research demonstrates the potential of large-scale patient data and AI to improve disease prediction and generate hypotheses for further investigation into disease mechanisms relevant to regional healthcare systems.

AI foundation model GluFormer outperforms clinical standards in forecasting diabetes and cardiovascular risk

MBZUAI ·

MBZUAI researchers co-led a study published in Nature demonstrating that GluFormer, an AI foundation model trained on continuous glucose monitoring (CGM) data, more accurately predicts long-term diabetes and cardiovascular risk than current clinical standards. GluFormer, built on a transformer architecture and trained using NVIDIA AI infrastructure on over 10 million CGM measurements, forecasts individual health risks using short-term glucose dynamics. In a 12-year follow-up, the model captured 66% of new-onset diabetes cases and 69% of cardiovascular-death events in its highest-risk group, outperforming established CGM-derived metrics across 19 external cohorts. Why it matters: The development of GluFormer represents a significant advancement in personalized healthcare, enabling proactive and individualized health strategies through the analysis of dynamic glucose data.